Avacta Group (LON:AVCT) Trading Up 11.7% – What’s Next?

Avacta Group Plc (LON:AVCTGet Free Report)’s share price rose 11.7% on Wednesday . The company traded as high as GBX 39 ($0.50) and last traded at GBX 37.70 ($0.49). Approximately 1,776,858 shares were traded during trading, an increase of 24% from the average daily volume of 1,430,634 shares. The stock had previously closed at GBX 33.75 ($0.43).

Avacta Group Stock Up 3.6 %

The business has a 50-day moving average price of GBX 46.49 and a two-hundred day moving average price of GBX 52.92. The company has a quick ratio of 4.96, a current ratio of 1.29 and a debt-to-equity ratio of 52.53. The firm has a market cap of £142.66 million, a PE ratio of -4.83 and a beta of 1.12.

About Avacta Group

(Get Free Report)

Avacta Therapeutics is a clinical stage biopharmaceutical company challenging current drug delivery methods to expand the utility of highly potent cancer therapeutics.
The Company benefits from a world class research and development facility, team of exceptionally talented scientists and a highly experienced management team with members located in both the London headquarters and the US.

Our proprietary pre|CISION® platform masks toxic warheads by binding them to a short, engineered peptide that is cleavable only by the tumor-specific protease, fibroblast activation protein (FAP).

Recommended Stories

Receive News & Ratings for Avacta Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Avacta Group and related companies with MarketBeat.com's FREE daily email newsletter.